SK Bioscience Forecast, price target & analysts
SK Bioscience Target price 2025 - Analyst rating & recommendation
SK Bioscience Classifications & Recommendation:
SK Bioscience Price Target
| Target Price | KRW36,210.00 |
| Price | KRW48,000.00 |
| Deviation |
24.56%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target SK Bioscience 2026 .
The average SK Bioscience target price is KRW36,210.00.
This is
24.56%
register free of charge
KRW63,000.00
31.25%
register free of charge
KRW25,250.00
47.40%
register free of charge
|
|
| A rating was issued by 11 analysts: 1 Analysts recommend SK Bioscience to buy, 4 to hold and 6 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the SK Bioscience stock has an average upside potential 2026 of
24.56%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion KRW | 267.55 | 636.83 |
| 27.59% | 138.03% | |
| EBITDA Margin | -48.41% | 1.00% |
| 2,809.38% | 102.07% | |
| Net Margin | -18.73% | -12.19% |
| 410.14% | 34.92% |
7 Analysts have issued a sales forecast SK Bioscience 2025 . The average SK Bioscience sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an SK Bioscience EBITDA forecast 2025. The average SK Bioscience EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 SK Bioscience Analysts have issued a net profit forecast 2025. The average SK Bioscience net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share KRW | -649.17 | -990.50 |
| 324.01% | 52.58% | |
| P/E | negative | |
| EV/Sales | 4.81 |
6 Analysts have issued a SK Bioscience forecast for earnings per share. The average SK Bioscience EPS is
This results in the following potential growth metrics and future valuations:
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
